216
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Prognostic impact of micromegakaryocytes in primary myelodysplastic syndromes

, , , , , , , , , , , ORCID Icon, , , , , , , ORCID Icon, & show all
Pages 1227-1235 | Received 11 Sep 2021, Accepted 06 Dec 2021, Published online: 31 Dec 2021

References

  • Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon (France): IARC Press; 2017.
  • Cazzola M. Myelodysplastic syndromes. N Engl J Med. 2020;383(14):1358–1374.
  • Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–2465.
  • Malcovati L, Hellström-Lindberg E, Bowen D, et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood. 2013;122(17):2943–2964.
  • Kuriyama K, Tomonaga M, Matsuo T, et al. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome. Br J Haematol. 1986;63(4):665–669.
  • Matsuda A, Germing U, Jinnai I, et al. Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification. Leukemia. 2007;21(4):678–686.
  • Feng G, Gale RP, Cui W, et al. A systematic classification of megakaryocytic dysplasia and its impact on prognosis for patients with myelodysplastic syndromes. Exp Hematol Oncol. 2015;5(1):12.
  • Weinberg OK, Gibson CJ, Blonquist TM, et al. Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO classification-defined cytogenetic abnormalities. Haematologica. 2018;103(4):626–633.
  • Goasguen JE, Bennett JM, Bain BJ, et al. Quality control initiative on the evaluation of the dysmegakaryopoiesis in myeloid neoplasms: difficulties in the assessment of dysplasia. Leuk Res. 2016;45:75–81.
  • Florensa L, Arenillas L, Calvo X, et al. The importance of adequate recognition of normal and dysplastic myelopoiesis for the diagnosis of myelodysplastic syndromes. Histol Histopathol. 2019;34(8):857–873.
  • Senent L, Arenillas L, Luño E, et al. Reproducibility of the world health organization 2008 criteria for myelodysplastic syndromes. Haematologica. 2013;98(4):568–575.
  • Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163.
  • Schanz J, Tüchler H, Solé F, et al. New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol. 2012;30(8):820–829.
  • Della Porta MG, Tuechler H, Malcovati L, et al. Validation of WHO classification-based prognostic scoring system (WPSS) for myelodysplastic syndromes and comparison with the revised international prognostic scoring system (IPSS-R). a study of the international working group for prognosis in Myelodysplasia (IWG-PM). Leukemia. 2015;29(7):1502–1513.
  • Germing U, Strupp C, Giagounidis A, et al. Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes. Leuk Res. 2012;36(6):727–734.
  • Mattia G, Vulcano F, Milazzo L, et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood. 2002;99(3):888–897.
  • Mazzi S, Lordier L, Debili N, et al. Megakaryocyte and polyploidization. Exp Hematol. 2018;57:1–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.